SCPH 5.65 ▲ 0.71% Live Trading Data - Stocknear

scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
5.65
0.04 (0.71%)
At close: Sep 26, 2025, 3:59 PM
5.63
-0.35%
After-hours: Sep 26, 2025, 07:25 PM EDT
0.71%
Bid 5.63
Market Cap 301.14M
Revenue (ttm) 49.97M
Net Income (ttm) -91.72M
EPS (ttm) -1.81
PE Ratio (ttm) -3.12
Forward PE -35.06
Analyst Hold
Dividends n/a
Ask 5.68
Volume 852,043
Avg. Volume (20D) 1,089,853
Open 5.63
Previous Close 5.61
Day's Range 5.62 - 5.65
52-Week Range 1.94 - 6.28
Beta 0.35
Ex-Dividend Date n/a

About SCPH

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCPH
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SCPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
scPharmaceuticals Inc. is scheduled to release its earnings on Nov 12, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+28.57%
scPharmaceuticals shares are trading higher after ... Unlock content with Pro Subscription
6 months ago
-1.89%
scPharmaceuticals shares are trading higher after the company announced FDA approval for a supplemental new drug application expanding the FUROSCIX indication to include the treatment of edema in patients with chronic kidney disease.